# Comparison of P wave indices between ultramarathon athletes and general population

**Authors:** Narawudt Prasertwitayakij, Pongsatorn Tungsuk, Sirianong Namwongprom, Teerapat Nantsupawat, Siriluck Gunaparn, Arintaya Phrommintikul, Wanwarang Wongcharoen

PMC · DOI: 10.14814/phy2.70766 · Physiological Reports · 2026-02-16

## TL;DR

Ultramarathon athletes show abnormal heart electrical patterns linked to higher risk of arrhythmias compared to the general population.

## Contribution

This study is the first to compare P wave indices in ultramarathon athletes and healthy controls, revealing significant atrial electrical remodeling.

## Key findings

- Ultramarathon athletes had significantly higher P wave duration, dispersion, PTFV1, and PWAII compared to controls.
- Abnormal P wave duration and PTFV1 were more prevalent in ultramarathon athletes than in controls.

## Abstract

High‐intensity endurance exercise is linked to increased atrial fibrillation (AF) risk. P wave indices are established AF risk markers, but their role in ultramarathon athletes is unexplored. This study aimed to compare P wave indices between ultramarathon athletes and healthy controls. This cross‐sectional study enrolled 74 ultramarathon athletes and 38 age‐ and sex‐matched healthy volunteers (2:1 ratio). Athletes had completed ≥1 race of ≥100 km or ≥60 km in the past year. Participants with AF, atrial flutter, cardiovascular diseases, or structural heart abnormalities were excluded. Resting 12‐lead ECGs evaluated P wave indices: maximum P wave duration, P wave dispersion, P wave terminal force in lead V1 (PTFV1), and P wave amplitude in lead II (PWAII). The cohort's mean age was 44.8 ± 8.2 years, 70% male. Ultramarathon athletes had significantly higher maximum P wave duration (114.24 ± 7.95 ms vs. 105.76 ± 7.15 ms, p < 0.001), P wave dispersion (18.77 ± 5.75 ms vs. 7.87 ± 2.51 ms, p < 0.001), PTFV1 (5795.66 ± 3212.27 μV·ms vs. 2399.17 ± 1140.19 μV·ms, p < 0.001) and PWAII (0.16 ± 0.05 mV vs. 0.12 ± 0.04 mV). Abnormal P wave duration (>120 ms) and PTFV1 (≥4000 μV·ms) were significantly more prevalent in ultramarathon athletes (25.7% vs. 5.3%, p = 0.010; 63.5% vs. 5.3%, p < 0.001). Similar findings were observed across genders. Ultramarathon runners demonstrate significant atrial electrical remodeling, as evidenced by abnormal P wave indices, may have potential relevance to arrhythmia risk. Further longitudinal studies are warranted to assess clinical outcomes.

## Linked entities

- **Diseases:** atrial fibrillation (MONDO:0004981), atrial flutter (MONDO:0005310)

## Full-text entities

- **Diseases:** atrial (MESH:D064752), atrial fibrosis (MESH:D005355), stroke (MESH:D020521), arrhythmia (MESH:D001145), heart abnormalities (MESH:D006330), cardiovascular diseases (MESH:D002318), AF (MESH:D001281), ventricular stiffness (MESH:C566112), atrial flutter (MESH:D001282), atrial abnormality (MESH:D000014), cardiac remodeling (MESH:D020257), atrial enlargement (MESH:D006332), heart disease (MESH:D006331), coronary artery disease (MESH:D003324), tricuspid regurgitation (MESH:D014262), heart failure (MESH:D006333)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12910118/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12910118/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12910118/full.md

---
Source: https://tomesphere.com/paper/PMC12910118